Journal Information
Statistics
Follow this link to access the full text of the article
Scientific letters
Recurrent skin reaction at the site of former subcutaneous injection after switching back to intravenous vedolizumab
Reacción cutánea recurrente en el sitio de punción de vedolizumab subcutáneo tras cambio a vedolizumab endovenoso